ReP USP - Resultado da busca

Artigo de periodico
Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability (2024)
Hernandez, Carolina Dagli; Ferreira, Glaucio Monteiro ; Freitas, Renata Caroline Costa de ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de; Gonçalves, Rodrigo Marques; Faludi, Andre Arpad; Marçal, Elisangela da Silva Rodrigues; Bastos, Gisele Medeiros ; Bortolin, Raul Hernandes ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Pharmacogenetics and Genomics. Unidades: FCF, IDPC
Assuntos: HIPERCOLESTEROLEMIA, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability. Pharmacogenetics and Genomics, v. 34, n. 4, p. 91-104, 2024Tradução . . Disponível em: https://dx.doi.org/10.1097/FPC.0000000000000524. Acesso em: 05 out. 2024.
APA
Hernandez, C. D., Ferreira, G. M., Freitas, R. C. C. de, Borges, J. B., Oliveira, V. F. de, Gonçalves, R. M., et al. (2024). Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability. Pharmacogenetics and Genomics, 34( 4), 91-104. doi:10.1097/FPC.0000000000000524
NLM
Hernandez CD, Ferreira GM, Freitas RCC de, Borges JB, Oliveira VF de, Gonçalves RM, Faludi AA, Marçal E da SR, Bastos GM, Bortolin RH, Hirata MH, Hirata RDC. Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability [Internet]. Pharmacogenetics and Genomics. 2024 ; 34( 4): 91-104.[citado 2024 out. 05 ] Available from: https://dx.doi.org/10.1097/FPC.0000000000000524
Vancouver
Hernandez CD, Ferreira GM, Freitas RCC de, Borges JB, Oliveira VF de, Gonçalves RM, Faludi AA, Marçal E da SR, Bastos GM, Bortolin RH, Hirata MH, Hirata RDC. Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability [Internet]. Pharmacogenetics and Genomics. 2024 ; 34( 4): 91-104.[citado 2024 out. 05 ] Available from: https://dx.doi.org/10.1097/FPC.0000000000000524
Artigo de periodico
Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells (2023)
Los, Bruna ; Ferreira, Glaucio Monteiro ; Borges, Jéssica Bassani ; Kronenberger, Thales ; Oliveira, Victor Fernandes de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M ; Faludi, André Arpad; Mori, Augusto Akira ; Barbosa, Thais Kristini Almendros; Freitas, Renata Caroline Costa de ; Jannes, Cinthia Elim ; Pereira, Alexandre da Costa; Bastos, Gisele Medeiros ; Poso, Antti ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Gene. Unidades: FM, FCF
Assuntos: HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells. Gene, v. 851, p. 1-14 art. 146979, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.gene.2022.146979. Acesso em: 05 out. 2024.
APA
Los, B., Ferreira, G. M., Borges, J. B., Kronenberger, T., Oliveira, V. F. de, Hernandez, C. D., et al. (2023). Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells. Gene, 851, 1-14 art. 146979. doi:10.1016/j.gene.2022.146979
NLM
Los B, Ferreira GM, Borges JB, Kronenberger T, Oliveira VF de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Mori AA, Barbosa TKA, Freitas RCC de, Jannes CE, Pereira A da C, Bastos GM, Poso A, Hirata RDC, Hirata MH. Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells [Internet]. Gene. 2023 ; 851 1-14 art. 146979.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.gene.2022.146979
Vancouver
Los B, Ferreira GM, Borges JB, Kronenberger T, Oliveira VF de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Mori AA, Barbosa TKA, Freitas RCC de, Jannes CE, Pereira A da C, Bastos GM, Poso A, Hirata RDC, Hirata MH. Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells [Internet]. Gene. 2023 ; 851 1-14 art. 146979.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.gene.2022.146979
Artigo de periodico
In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia (2023)
Araújo, Jéssica Nayara Góes de ; Oliveira, Victor Fernandes de ; Borges, Jéssica Bassani ; Hernandez, Carolina Dagli ; Marçal, Elisangela da Silva Rodrigues; Freitas, Renata Caroline Costa de ; Bastos, Gisele Medeiros ; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Jannes, Cinthia Elim; Pereira, Alexandre da Costa ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati ; Silbiger, Vivian Nogueira
Fonte: Gene. Unidades: FM, FCF
Assuntos: HIPERCOLESTEROLEMIA, GENOMAS, BIOINFORMÁTICA, NUCLEOTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAÚJO, Jéssica Nayara Góes de et al. In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia. Gene, v. 849, p. 1-7 art. 146908, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.gene.2022.146908. Acesso em: 05 out. 2024.
APA
Araújo, J. N. G. de, Oliveira, V. F. de, Borges, J. B., Hernandez, C. D., Marçal, E. da S. R., Freitas, R. C. C. de, et al. (2023). In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia. Gene, 849, 1-7 art. 146908. doi:10.1016/j.gene.2022.146908
NLM
Araújo JNG de, Oliveira VF de, Borges JB, Hernandez CD, Marçal E da SR, Freitas RCC de, Bastos GM, Gonçalves RM, Faludi AA, Jannes CE, Pereira A da C, Hirata RDC, Hirata MH, Luchessi AD, Silbiger VN. In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia [Internet]. Gene. 2023 ; 849 1-7 art. 146908.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.gene.2022.146908
Vancouver
Araújo JNG de, Oliveira VF de, Borges JB, Hernandez CD, Marçal E da SR, Freitas RCC de, Bastos GM, Gonçalves RM, Faludi AA, Jannes CE, Pereira A da C, Hirata RDC, Hirata MH, Luchessi AD, Silbiger VN. In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia [Internet]. Gene. 2023 ; 849 1-7 art. 146908.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.gene.2022.146908
Artigo de periodico
LDLR missense variants disturb structural conformation and LDLR activity in T-lymphocytes of Familial hypercholesterolemia patients (2023)
Barbosa, Thais Kristini Almendros; Hirata, Rosario Dominguez Crespo ; Ferreira, Glaucio Monteiro ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Gorjão, Renata ; Marçal, Elisangela Rodrigues da Silva; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Freitas, Renata Caroline Costa de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Bastos, Gisele Medeiros ; Curi, Tania Cristina Pithon ; Nader, Helena Bonciani; Hirata, Mario Hiroyuki
Fonte: Gene. Unidade: FCF
Assuntos: LINFÓCITOS T, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Thais Kristini Almendros et al. LDLR missense variants disturb structural conformation and LDLR activity in T-lymphocytes of Familial hypercholesterolemia patients. Gene, v. 853, p. 1-14 art. 147084, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.gene.2022.147084. Acesso em: 05 out. 2024.
APA
Barbosa, T. K. A., Hirata, R. D. C., Ferreira, G. M., Borges, J. B., Oliveira, V. F. de, Gorjão, R., et al. (2023). LDLR missense variants disturb structural conformation and LDLR activity in T-lymphocytes of Familial hypercholesterolemia patients. Gene, 853, 1-14 art. 147084. doi:10.1016/j.gene.2022.147084
NLM
Barbosa TKA, Hirata RDC, Ferreira GM, Borges JB, Oliveira VF de, Gorjão R, Marçal ER da S, Gonçalves RM, Faludi AA, Freitas RCC de, Hernandez CD, Bortolin RH, Bastos GM, Curi TCP, Nader HB, Hirata MH. LDLR missense variants disturb structural conformation and LDLR activity in T-lymphocytes of Familial hypercholesterolemia patients [Internet]. Gene. 2023 ; 853 1-14 art. 147084.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.gene.2022.147084
Vancouver
Barbosa TKA, Hirata RDC, Ferreira GM, Borges JB, Oliveira VF de, Gorjão R, Marçal ER da S, Gonçalves RM, Faludi AA, Freitas RCC de, Hernandez CD, Bortolin RH, Bastos GM, Curi TCP, Nader HB, Hirata MH. LDLR missense variants disturb structural conformation and LDLR activity in T-lymphocytes of Familial hypercholesterolemia patients [Internet]. Gene. 2023 ; 853 1-14 art. 147084.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.gene.2022.147084
Artigo de periodico
Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia (2023)
Cerda, Alvaro; Bortolin, Raul Hernandes ; Yoshinaga, Marcos Yukio ; Freitas, Renata Caroline Costa de ; Hernandez, Carolina Dagli; Borges, Jessica Bassani; Oliveira, Victor Fernandes de ; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Bastos, Gisele Medeiros ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Chemistry and Physics of Lipids. Unidades: FCF, ICB
Assuntos: BIOMARCADORES, ESTATINAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia. Chemistry and Physics of Lipids, v. 257, p. 1-9 art. 105348, 2023Tradução . . Disponível em: https://dx.doi.org/10.1016/j.chemphyslip.2023.105348. Acesso em: 05 out. 2024.
APA
Cerda, A., Bortolin, R. H., Yoshinaga, M. Y., Freitas, R. C. C. de, Hernandez, C. D., Borges, J. B., et al. (2023). Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia. Chemistry and Physics of Lipids, 257, 1-9 art. 105348. doi:10.1016/j.chemphyslip.2023.105348
NLM
Cerda A, Bortolin RH, Yoshinaga MY, Freitas RCC de, Hernandez CD, Borges JB, Oliveira VF de, Gonçalves RM, Faludi AA, Bastos GM, Hirata RDC, Hirata MH. Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia [Internet]. Chemistry and Physics of Lipids. 2023 ; 257 1-9 art. 105348.[citado 2024 out. 05 ] Available from: https://dx.doi.org/10.1016/j.chemphyslip.2023.105348
Vancouver
Cerda A, Bortolin RH, Yoshinaga MY, Freitas RCC de, Hernandez CD, Borges JB, Oliveira VF de, Gonçalves RM, Faludi AA, Bastos GM, Hirata RDC, Hirata MH. Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia [Internet]. Chemistry and Physics of Lipids. 2023 ; 257 1-9 art. 105348.[citado 2024 out. 05 ] Available from: https://dx.doi.org/10.1016/j.chemphyslip.2023.105348
Artigo de periodico
LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach (2023)
Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de; Hernandez, Carolina Dagli ; Marçal, Elisangela da Silva Rodrigues; Bastos, Gisele Medeiros ; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Silbiger, Vivian Nogueira ; Luchessi, Andre Ducati ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Molecular Biology Reports. Unidades: IDPC, FCF
Assuntos: MICRORNAS, HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach. Molecular Biology Reports, v. 50, n. 11, p. 9165-9177, 2023Tradução . . Disponível em: https://dx.doi.org/10.1007/s11033-023-08784-9. Acesso em: 05 out. 2024.
APA
Freitas, R. C. C. de, Bortolin, R. H., Borges, J. B., Oliveira, V. F. de, Hernandez, C. D., Marçal, E. da S. R., et al. (2023). LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach. Molecular Biology Reports, 50( 11), 9165-9177. doi:10.1007/s11033-023-08784-9
NLM
Freitas RCC de, Bortolin RH, Borges JB, Oliveira VF de, Hernandez CD, Marçal E da SR, Bastos GM, Gonçalves RM, Faludi AA, Silbiger VN, Luchessi AD, Hirata RDC, Hirata MH. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach [Internet]. Molecular Biology Reports. 2023 ; 50( 11): 9165-9177.[citado 2024 out. 05 ] Available from: https://dx.doi.org/10.1007/s11033-023-08784-9
Vancouver
Freitas RCC de, Bortolin RH, Borges JB, Oliveira VF de, Hernandez CD, Marçal E da SR, Bastos GM, Gonçalves RM, Faludi AA, Silbiger VN, Luchessi AD, Hirata RDC, Hirata MH. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach [Internet]. Molecular Biology Reports. 2023 ; 50( 11): 9165-9177.[citado 2024 out. 05 ] Available from: https://dx.doi.org/10.1007/s11033-023-08784-9
Artigo de periodico
Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts (2022)
Hernandez, Carolina Dagli ; Zhou, Yitian; Lauschke, Volker Martin; Genvigir, Fabiana Dalla Vecchia ; Hirata, Thiago Dominguez Crespo ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Pharmacological Reports. Unidade: FCF
Assuntos: ESTATINAS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports, v. 74, p. 47–66, 2022Tradução . . Disponível em: https://doi.org/10.1007/s43440-021-00319-y. Acesso em: 05 out. 2024.
APA
Hernandez, C. D., Zhou, Y., Lauschke, V. M., Genvigir, F. D. V., Hirata, T. D. C., Hirata, M. H., & Hirata, R. D. C. (2022). Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports, 74, 47–66. doi:10.1007/s43440-021-00319-y
NLM
Hernandez CD, Zhou Y, Lauschke VM, Genvigir FDV, Hirata TDC, Hirata MH, Hirata RDC. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts [Internet]. Pharmacological Reports. 2022 ; 74 47–66.[citado 2024 out. 05 ] Available from: https://doi.org/10.1007/s43440-021-00319-y
Vancouver
Hernandez CD, Zhou Y, Lauschke VM, Genvigir FDV, Hirata TDC, Hirata MH, Hirata RDC. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts [Internet]. Pharmacological Reports. 2022 ; 74 47–66.[citado 2024 out. 05 ] Available from: https://doi.org/10.1007/s43440-021-00319-y
Tese (Doutorado)
Pharmacogenomic analysis in patients with familial hypercholesterolemia (2022)
Hernandez, Carolina Dagli ; Hirata, Rosario Dominguez Crespo (Orientador)
Unidade: FCF
Assuntos: FARMACOGENÉTICA, HIPERCOLESTEROLEMIA, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli. Pharmacogenomic analysis in patients with familial hypercholesterolemia. 2022. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2022. Disponível em: https://www.teses.usp.br/teses/disponiveis/9/9142/tde-20052022-121840/. Acesso em: 05 out. 2024.
APA
Hernandez, C. D. (2022). Pharmacogenomic analysis in patients with familial hypercholesterolemia (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de https://www.teses.usp.br/teses/disponiveis/9/9142/tde-20052022-121840/
NLM
Hernandez CD. Pharmacogenomic analysis in patients with familial hypercholesterolemia [Internet]. 2022 ;[citado 2024 out. 05 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9142/tde-20052022-121840/
Vancouver
Hernandez CD. Pharmacogenomic analysis in patients with familial hypercholesterolemia [Internet]. 2022 ;[citado 2024 out. 05 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9142/tde-20052022-121840/
Artigo de periodico
Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia (2022)
Hernandez, Carolina Dagli ; Borges, Jéssica Bassani ; Marçal, Elisangela da Silva Rodrigues; Freitas, Renata Caroline Costa de ; Mori, Augusto Akira ; Gonçalves, Rodrigo Marques; Faludi, André Arpad ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Bastos, Gisele Medeiros ; Zhou, Yitian ; Lauschke, Volker Martin ; Cerda, Alvaro ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Pharmaceutics. Unidade: FCF
Assuntos: HIPERCOLESTEROLEMIA, ESTATINAS, VARIAÇÃO GENÉTICA, FARMACOGENÉTICA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia. Pharmaceutics, v. 14, p. 1-20 art. 944, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14050944. Acesso em: 05 out. 2024.
APA
Hernandez, C. D., Borges, J. B., Marçal, E. da S. R., Freitas, R. C. C. de, Mori, A. A., Gonçalves, R. M., et al. (2022). Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia. Pharmaceutics, 14, 1-20 art. 944. doi:10.3390/pharmaceutics14050944
NLM
Hernandez CD, Borges JB, Marçal E da SR, Freitas RCC de, Mori AA, Gonçalves RM, Faludi AA, Oliveira VF de, Ferreira GM, Bastos GM, Zhou Y, Lauschke VM, Cerda A, Hirata MH, Hirata RDC. Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia [Internet]. Pharmaceutics. 2022 ; 14 1-20 art. 944.[citado 2024 out. 05 ] Available from: https://doi.org/10.3390/pharmaceutics14050944
Vancouver
Hernandez CD, Borges JB, Marçal E da SR, Freitas RCC de, Mori AA, Gonçalves RM, Faludi AA, Oliveira VF de, Ferreira GM, Bastos GM, Zhou Y, Lauschke VM, Cerda A, Hirata MH, Hirata RDC. Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia [Internet]. Pharmaceutics. 2022 ; 14 1-20 art. 944.[citado 2024 out. 05 ] Available from: https://doi.org/10.3390/pharmaceutics14050944
Artigo de periodico
Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia (2021)
Los, Bruna ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Freitas, Renata Caroline Costa de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M ; Faludi, André Arpad ; Rodrigues, Alice Cristina ; Bastos, Gisele Medeiros ; Jannes, Cinthia Elim ; Pereira , Alexandre C ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Epigenomics. Unidades: IDPC, ICB, FCF
Assuntos: HIPERCOLESTEROLEMIA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, v. 13, n. 10, p. 779–791, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0462. Acesso em: 05 out. 2024.
APA
Los, B., Borges, J. B., Oliveira, V. F. de, Freitas, R. C. C. de, Hernandez, C. D., Bortolin, R. H., et al. (2021). Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, 13( 10), 779–791. doi:10.2217/epi-2020-0462
NLM
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Rodrigues AC, Bastos GM, Jannes CE, Pereira AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 out. 05 ] Available from: https://doi.org/10.2217/epi-2020-0462
Vancouver
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Rodrigues AC, Bastos GM, Jannes CE, Pereira AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 out. 05 ] Available from: https://doi.org/10.2217/epi-2020-0462
Artigo de periodico
Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients (2021)
Hirata, Thiago Dominguez Crespo ; Hernandez, Carolina Dagli ; Genvigir, Fabiana Dalla Vecchia ; Lauschke, Volker Martin ; Zhou, Yitian ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Molecular Diagnosis and Therapy. Unidade: FCF
Assuntos: ANTICOAGULANTES, DOENÇAS CARDIOVASCULARES, TROMBOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Thiago Dominguez Crespo et al. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients. Molecular Diagnosis and Therapy, v. 25, p. 735–755, 2021Tradução . . Disponível em: https://doi.org/10.1007/s40291-021-00549-z. Acesso em: 05 out. 2024.
APA
Hirata, T. D. C., Hernandez, C. D., Genvigir, F. D. V., Lauschke, V. M., Zhou, Y., Hirata, M. H., & Hirata, R. D. C. (2021). Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients. Molecular Diagnosis and Therapy, 25, 735–755. doi:10.1007/s40291-021-00549-z
NLM
Hirata TDC, Hernandez CD, Genvigir FDV, Lauschke VM, Zhou Y, Hirata MH, Hirata RDC. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients [Internet]. Molecular Diagnosis and Therapy. 2021 ; 25 735–755.[citado 2024 out. 05 ] Available from: https://doi.org/10.1007/s40291-021-00549-z
Vancouver
Hirata TDC, Hernandez CD, Genvigir FDV, Lauschke VM, Zhou Y, Hirata MH, Hirata RDC. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients [Internet]. Molecular Diagnosis and Therapy. 2021 ; 25 735–755.[citado 2024 out. 05 ] Available from: https://doi.org/10.1007/s40291-021-00549-z
Trabalho de evento
Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina (2021)
Rodrigues, Vitor Pitta; Araujo, Neire Niara Ferreira de; Bastos, Gisele Medeiros ; Hernandez, Carolina Dagli ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Posters. Nome do evento: Reunião Anual da SBPC (Virtual). Unidade: FCF
Assuntos: ANTICOAGULANTES, POLIMORFISMO, GENÉTICA, FARMACOGENÉTICA, IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Vitor Pitta et al. Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina. 2021, Anais.. São Paulo: SBPC, 2021. Disponível em: https://reunioes.sbpcnet.org.br/73RA/inscritos/resumos/10242_1f340f1b1f65b6df5b5e3f94d95b11daf.pdf. Acesso em: 05 out. 2024.
APA
Rodrigues, V. P., Araujo, N. N. F. de, Bastos, G. M., Hernandez, C. D., Hirata, R. D. C., & Hirata, M. H. (2021). Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina. In Posters. São Paulo: SBPC. Recuperado de https://reunioes.sbpcnet.org.br/73RA/inscritos/resumos/10242_1f340f1b1f65b6df5b5e3f94d95b11daf.pdf
NLM
Rodrigues VP, Araujo NNF de, Bastos GM, Hernandez CD, Hirata RDC, Hirata MH. Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina [Internet]. Posters. 2021 ;[citado 2024 out. 05 ] Available from: https://reunioes.sbpcnet.org.br/73RA/inscritos/resumos/10242_1f340f1b1f65b6df5b5e3f94d95b11daf.pdf
Vancouver
Rodrigues VP, Araujo NNF de, Bastos GM, Hernandez CD, Hirata RDC, Hirata MH. Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina [Internet]. Posters. 2021 ;[citado 2024 out. 05 ] Available from: https://reunioes.sbpcnet.org.br/73RA/inscritos/resumos/10242_1f340f1b1f65b6df5b5e3f94d95b11daf.pdf
Artigo de periodico
Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol (2021)
Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Los, Bruna; Barbosa, Thais Kristini Almendros Afonso; Marçal, Elisangela da Silva Rodrigues; Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Mori, Augusto Akira ; Hirata, Thiago Dominguez Crespo ; Nakaya, Helder Takashi Imoto ; Bastos, Gisele Medeiros ; Thurow, Helena Strelow ; Gonçalves, Rodrigo Marques; Araújo, Daniel Branco de; Zatz, Henry Paulo; Bertolami, Adriana; Faludi, André Arpad; Bertolami, Marcelo Chiara ; Sousa, Amanda Guerra de Moraes Rego ; França, Joao Italo Dias ; Jannes, Cinthia Elim; Pereira, Alexandre da Costa; Nakazone, Marcelo Arruda; Souza, Dorotéia Rossi Silva; Carmo, Tayanne Silva; Sampaio, Marcelo Ferraz; Gorjão, Renata ; Curi, Tania Cristina Pithon ; Moriel, Patricia; Silbiger, Vivian Nogueira ; Luchessi, André Ducati ; Araújo, Jéssica Nayara Góes de; Naslavsky, Michel ; Wang, Jaqueline Yu Ting; Kronenberger, Thales ; Cerda, Alvaro ; Wang, Hui Tzu Lin; Garofalo, Adriana Regina; Fajardo, Cristina Moreno ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Research in Social and Administrative Pharmacy. Unidades: FCF, IDPC, FM, IB
Assuntos: GENÔMICA, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, EXONS, LINFÓCITOS, LINHAGEM CELULAR, MUTAGÊNESE, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jéssica Bassani et al. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, v. 17, n. 7, p. 1347-1355, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2020.10.007. Acesso em: 05 out. 2024.
APA
Borges, J. B., Oliveira, V. F. de, Ferreira, G. M., Los, B., Barbosa, T. K. A. A., Marçal, E. da S. R., et al. (2021). Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, 17( 7), 1347-1355. doi:10.1016/j.sapharm.2020.10.007
NLM
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Vancouver
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Artigo de periodico
Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report (2021)
Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Marçal, Elisangela da Silva Rodrigues; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Borges, Jéssica Bassani ; Bastos, Gisele Medeiros ; Los, Bruna; Mori, Augusto Akira ; Bortolin, Raul Hernandes ; Ferreira, Glaucio Monteiro ; Oliveira, Victor Fernandes de ; Hirata, Thiago Dominguez Crespo ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Annals of Translational Medicine. Unidades: IDPC, FCF
Assuntos: HIPERCOLESTEROLEMIA, ESTATINAS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report. Annals of Translational Medicine, v. 9, n. 1, p. 1-8 art. 76, 2021Tradução . . Disponível em: https://doi.org/10.21037/atm-20-5540. Acesso em: 05 out. 2024.
APA
Hernandez, C. D., Freitas, R. C. C. de, Marçal, E. da S. R., Gonçalves, R. M., Faludi, A. A., Borges, J. B., et al. (2021). Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report. Annals of Translational Medicine, 9( 1), 1-8 art. 76. doi:10.21037/atm-20-5540
NLM
Hernandez CD, Freitas RCC de, Marçal E da SR, Gonçalves RM, Faludi AA, Borges JB, Bastos GM, Los B, Mori AA, Bortolin RH, Ferreira GM, Oliveira VF de, Hirata TDC, Hirata MH, Hirata RDC. Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report [Internet]. Annals of Translational Medicine. 2021 ; 9( 1): 1-8 art. 76.[citado 2024 out. 05 ] Available from: https://doi.org/10.21037/atm-20-5540
Vancouver
Hernandez CD, Freitas RCC de, Marçal E da SR, Gonçalves RM, Faludi AA, Borges JB, Bastos GM, Los B, Mori AA, Bortolin RH, Ferreira GM, Oliveira VF de, Hirata TDC, Hirata MH, Hirata RDC. Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report [Internet]. Annals of Translational Medicine. 2021 ; 9( 1): 1-8 art. 76.[citado 2024 out. 05 ] Available from: https://doi.org/10.21037/atm-20-5540
Artigo de periodico
Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia (2021)
Los, Bruna ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Freitas, Renata Carolina Costa de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M. ; Faludi, André A. ; Bastos, Gisele M. ; Jannes, Cinthia E. ; Pereira, Alexandre C. ; Rodrigues, Alice Cristina ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Epigenomics. Unidades: ICB, FCF
Assuntos: FARMACOLOGIA, HIPERCOLESTEROLEMIA, VARIAÇÃO GENÉTICA, MICRORNAS, ENVELHECIMENTO, RNA MENSAGEIRO, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, v. 13, n. 10, p. 779–791, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0462. Acesso em: 05 out. 2024.
APA
Los, B., Borges, J. B., Oliveira, V. F. de, Freitas, R. C. C. de, Hernandez, C. D., Bortolin, R. H., et al. (2021). Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, 13( 10), 779–791. doi:10.2217/epi-2020-0462
NLM
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Bastos GM, Jannes CE, Pereira AC, Rodrigues AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 out. 05 ] Available from: https://doi.org/10.2217/epi-2020-0462
Vancouver
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Bastos GM, Jannes CE, Pereira AC, Rodrigues AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 out. 05 ] Available from: https://doi.org/10.2217/epi-2020-0462
Trabalho de evento-resumo
miRNA predictive profile based on , and 3'UTR variants as potential biomarker for familial hypercholesterolemia (2019)
Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Borges, Jéssica Bassani; Los, Bruna; Hernandez, Carolina Dagli; Mori, Augusto Akira ; Oliveira, V. F; Ferreira, Glaucio Monteiro; Marçal, Elisangela da Silva Rodrigues; Bastos, G. M.; Fajardo, Cristina Moreno ; Gonçalves, R. M; Faludi, André Arpad; Luchessi, André Ducati; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Abstracts. Nome do evento: American Association for Clinical Chemistry/AACC. Unidade: FCF
Assuntos: HIPERCOLESTEROLEMIA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. miRNA predictive profile based on , and 3'UTR variants as potential biomarker for familial hypercholesterolemia. 2019, Anais.. Washington: AACC, 2019. . Acesso em: 05 out. 2024.
APA
Freitas, R. C. C. de, Bortolin, R. H., Borges, J. B., Los, B., Hernandez, C. D., Mori, A. A., et al. (2019). miRNA predictive profile based on , and 3'UTR variants as potential biomarker for familial hypercholesterolemia. In Abstracts. Washington: AACC.
NLM
Freitas RCC de, Bortolin RH, Borges JB, Los B, Hernandez CD, Mori AA, Oliveira VF, Ferreira GM, Marçal E da SR, Bastos GM, Fajardo CM, Gonçalves RM, Faludi AA, Luchessi AD, Hirata RDC, Hirata MH. miRNA predictive profile based on , and 3'UTR variants as potential biomarker for familial hypercholesterolemia. Abstracts. 2019 ;[citado 2024 out. 05 ]
Vancouver
Freitas RCC de, Bortolin RH, Borges JB, Los B, Hernandez CD, Mori AA, Oliveira VF, Ferreira GM, Marçal E da SR, Bastos GM, Fajardo CM, Gonçalves RM, Faludi AA, Luchessi AD, Hirata RDC, Hirata MH. miRNA predictive profile based on , and 3'UTR variants as potential biomarker for familial hypercholesterolemia. Abstracts. 2019 ;[citado 2024 out. 05 ]
Trabalho de evento-resumo periodico
Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events (2018)
Hernandez, Carolina Dagli; Borges, Jéssica Bassani; Los, Bruna; Faludi, André Arpad; Gonçalves, Rodrigo Marques; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Drug Metabolism and Personalized Therapy. Nome do evento: Santorini Conference Systems Medicine and Personalised Health & Therapy. Unidade: FCF
Assuntos: ESTATINAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events. Drug Metabolism and Personalized Therapy. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.1515/dmpt-2018-0024. Acesso em: 05 out. 2024. , 2018
APA
Hernandez, C. D., Borges, J. B., Los, B., Faludi, A. A., Gonçalves, R. M., Hirata, M. H., & Hirata, R. D. C. (2018). Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events. Drug Metabolism and Personalized Therapy. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1515/dmpt-2018-0024
NLM
Hernandez CD, Borges JB, Los B, Faludi AA, Gonçalves RM, Hirata MH, Hirata RDC. Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events [Internet]. Drug Metabolism and Personalized Therapy. 2018 ; 33( 3): eA52-eA53.[citado 2024 out. 05 ] Available from: https://doi.org/10.1515/dmpt-2018-0024
Vancouver
Hernandez CD, Borges JB, Los B, Faludi AA, Gonçalves RM, Hirata MH, Hirata RDC. Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events [Internet]. Drug Metabolism and Personalized Therapy. 2018 ; 33( 3): eA52-eA53.[citado 2024 out. 05 ] Available from: https://doi.org/10.1515/dmpt-2018-0024
Trabalho de evento-resumo
Characterization of the most frequent variants in a brazilian population with familial hypercholesterolemia (2018)
Borges, Jessica Bassabi; Thurow, Helena Strelow; Hernandez, Carolina Dagli; Freitas, Renata Carolina Costa; Bastos, Gisele Medeiros; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Abstracts. Nome do evento: Annual Clinical Genetics Meeting/ACMG. Unidade: FCF
Assuntos: HIPERCOLESTEROLEMIA, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jessica Bassabi et al. Characterization of the most frequent variants in a brazilian population with familial hypercholesterolemia. 2018, Anais.. Charlotte: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, 2018. . Acesso em: 05 out. 2024.
APA
Borges, J. B., Thurow, H. S., Hernandez, C. D., Freitas, R. C. C., Bastos, G. M., Gonçalves, R. M., et al. (2018). Characterization of the most frequent variants in a brazilian population with familial hypercholesterolemia. In Abstracts. Charlotte: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Borges JB, Thurow HS, Hernandez CD, Freitas RCC, Bastos GM, Gonçalves RM, Faludi AA, Hirata RDC, Hirata MH. Characterization of the most frequent variants in a brazilian population with familial hypercholesterolemia. Abstracts. 2018 ;[citado 2024 out. 05 ]
Vancouver
Borges JB, Thurow HS, Hernandez CD, Freitas RCC, Bastos GM, Gonçalves RM, Faludi AA, Hirata RDC, Hirata MH. Characterization of the most frequent variants in a brazilian population with familial hypercholesterolemia. Abstracts. 2018 ;[citado 2024 out. 05 ]
Trabalho de evento-resumo
Identification of the PCSK9 E32K gain-of-function mutation in a Brazilian patient with familial hypercholesterolemia: a case report (2018)
Los, Bruna; Hernandez, Carolina Dagli; Borges, Jéssica Bassani; Bastos, Gisele Medeiros; Faludi, André Arpad; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Resumos. Nome do evento: International Symposium on Pathophysiology and Toxicology/ISPAT. Unidade: FCF
Assuntos: LIPOPROTEÍNAS LDL, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Identification of the PCSK9 E32K gain-of-function mutation in a Brazilian patient with familial hypercholesterolemia: a case report. 2018, Anais.. São Paulo: FCF/USP, 2018. Disponível em: http://simpac.wixsite.com/simpac/symposium-publications. Acesso em: 05 out. 2024.
APA
Los, B., Hernandez, C. D., Borges, J. B., Bastos, G. M., Faludi, A. A., Hirata, R. D. C., & Hirata, M. H. (2018). Identification of the PCSK9 E32K gain-of-function mutation in a Brazilian patient with familial hypercholesterolemia: a case report. In Resumos. São Paulo: FCF/USP. Recuperado de http://simpac.wixsite.com/simpac/symposium-publications
NLM
Los B, Hernandez CD, Borges JB, Bastos GM, Faludi AA, Hirata RDC, Hirata MH. Identification of the PCSK9 E32K gain-of-function mutation in a Brazilian patient with familial hypercholesterolemia: a case report [Internet]. Resumos. 2018 ;[citado 2024 out. 05 ] Available from: http://simpac.wixsite.com/simpac/symposium-publications
Vancouver
Los B, Hernandez CD, Borges JB, Bastos GM, Faludi AA, Hirata RDC, Hirata MH. Identification of the PCSK9 E32K gain-of-function mutation in a Brazilian patient with familial hypercholesterolemia: a case report [Internet]. Resumos. 2018 ;[citado 2024 out. 05 ] Available from: http://simpac.wixsite.com/simpac/symposium-publications
Trabalho de evento-resumo periodico
Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia (2018)
Hernandez, Carolina Dagli; Borges, Jéssica Bassani; Faludi, André Arpad; Gonçalves, Rodrigo Marques; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Brazilian Journal of Pharmaceutical Sciences. Nome do evento: Congress of the Brazilian Association of Pharmaceutical Sciences/ABCF. Unidade: FCF
Assuntos: ESTATINAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf. Acesso em: 05 out. 2024. , 2018
APA
Hernandez, C. D., Borges, J. B., Faludi, A. A., Gonçalves, R. M., Hirata, M. H., & Hirata, R. D. C. (2018). Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
NLM
Hernandez CD, Borges JB, Faludi AA, Gonçalves RM, Hirata MH, Hirata RDC. Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 222 res. 423.[citado 2024 out. 05 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
Vancouver
Hernandez CD, Borges JB, Faludi AA, Gonçalves RM, Hirata MH, Hirata RDC. Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 222 res. 423.[citado 2024 out. 05 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf

Unidades USP

ReP

Filtros

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Nome do evento

País de publicação

Grupo de pesquisa

Agência de fomento

Afiliação dos autores externos não normalizada